Identifying therapeutic targets for schizophrenia
There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...
Saved in:
Main Author: | Karli Montague-Cardoso |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e8c68a00f79b4d2a84f00ab418323797 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-amyloid production in neurons is regulated by astrocyte-derived cholesterol
by: Karli Montague-Cardoso
Published: (2021) -
T cells in the brain may contribute to attenuation of sepsis-associated depression
by: Karli Montague-Cardoso
Published: (2021) -
Teasing apart the cell death pathways in HIV pathogenesis
by: Karli Montague-Cardoso
Published: (2021) -
Cellular proteostasis decline in human senescence
by: Karli Montague-Cardoso
Published: (2021) -
A DNA origami-based nanoscale molecular transport railway
by: Theam Soon Lim, et al.
Published: (2021)